SPL
Click for more information
0.00% 9.7¢ starpharma holdings limited

We are discussing DEP cancer drugs for pancreatic cancer. The...

  1. sarge17
    3,307 Posts.
    lightbulb Created with Sketch. 779
    clock Created with Sketch.
    27/03/24
    05:38
    Post #: 73073999
    We are discussing DEP cancer drugs for pancreatic cancer. The 100% false statement is below:

    ‘We know that DEP has been effective in Pancreatic cancer Phase 3 trials so maybe DEP is assisting minimising adverse effects of chemotherapy’
    ~@starlink

    Even you couldn't justify this incorrect and misleading statement.
    Last edited by sarge17: 27/03/24
    SPL Price at posting: 13.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MGT Magnetite Mines set to progress DFS for Razorback through deal with JFE Shoji
right-arrow Created with Sketch.
PMT High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%
right-arrow Created with Sketch.
HCH Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
right-arrow Created with Sketch.
ENR Encounter Resources flags latest niobium hits in fresh assay data
right-arrow Created with Sketch.
CXO Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
right-arrow Created with Sketch.
NEWS Good debt vs bad debt for the property in your investment portfolio
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $40.00M
Open High Low Value Volume
9.8¢ 10.5¢ 9.6¢ $210.8K 2.098M

Buyers (Bids)

No. Vol. Price($)
1 30408 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 3523 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.